ArticleCardiology and therapy2025

Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS.

Jonas Wixner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.